Worldwide Clinical Trials

Durham, NC Professional servicesNAICS 541700

Self-funded health planPlan year 2025Renews January
1,449Participants0% vs. prior year
$3.4MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#8 of 24Professional services in NCBy participants

Overview

Worldwide Clinical Trials sponsors a self-funded health plan that covered 1,449 participants in plan year 2025, about the same as the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
1,449 · prior year 1,449
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Worldwide Clinical Trials Holdings, Inc. Employee Benefits Plan, plan 501 (1,449 participants)
Broker compensation
$151K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityPrepaid legalLong-term disabilityOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Lincoln National Life Insurance CompanyShort-term disability, Life, Long-term disability1,418$646K$77K
Eyemed Vision CareVision2,249$226K$25K
The Lincoln National Life Insurance CompanyAccident, Hospital Indemnity514$169K$46K
Pre-Paid Legal Services Inc. DBA LegalshieldLegal Services Plan Memberships379$39K$3K

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$3.4M/ year

Estimated prescription spend: 1,449 participants × $2,371 national average per member. Usually higher once dependents are counted.

$89K–$220K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$26K–$65K
Lower-cost therapeutic alternatives$38K–$80K
Generic pricing vs. actual cost$16K–$49K
PBM contract terms$9K–$26K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Worldwide Clinical Trials
Sponsor EIN
26-1188036
Plan number
501
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 26-1188036 in the Department of Labor's EFAST2 Form 5500 search.

About this data

Source: Worldwide Clinical Trials's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Worldwide Clinical Trials.

Request a correction · Methodology